Retinol level in patients with psoriasis during treatment with B group vitamins, a bacterial polysaccharide (pyrogenal) and methotrexate (Russian)

A study of 160 patients with psoriasis revealed a reduction in the content of vitamin A in patients with various forms of psoriasis. During treatment with group B vitamins the best therapeutic effect was observed with vitamins B5 and B15. An increase of vitamin A in the blood was noted during treatment with vitamins B2 and pellagra preventive factor, whereas vitamins B1, B5, B6, B9, B12 and B15 caused a decline of the vitamin A level in the blood. During treatment of psoriatic patients with pyrogenal the content of vitamin A in the blood increased, while methotrexate therapy caused it to decrease. Vitamin A appears to be effective in the treatment of various forms of psoriasis both alone and in combination with methotrexate and vitamins B1, B5, B6, B9, B12 and B15

Pyridoxine metabolism in patients with skin leishmaniasis in Libya

Epidemiological screening carried out in Libya revealed 1539 patients with zoonotic skin leishmaniasis who were treated, with consideration for the indications, by glucantine, lincocine, vilbramycin, keflex, amoxil, tigason, nisoral, and levamisole. Good results were attained in 1237 (80.3%) patients. In 302 (19.7%) patients the treatment was ineffective; laboratory tests revealed in their blood a marked deficit of pyridoxine. An extra course of therapy of these patients with vitamin B6 preparations pyriditol and pyridoxal phosphate was conducive to complete cure of these patients and recovery of normal pyridoxine level in the blood

Retinol level in patients with psoriasis during treatment with B group vitamins, a bacterial polysaccharide (pyrogenal) and methotrexate (Russian)

A study of 160 patients with psoriasis revealed a reduction in the content of vitamin A in patients with various forms of psoriasis. During treatment with group B vitamins the best therapeutic effect was observed with vitamins B5 and B15. An increase of vitamin A in the blood was noted during treatment with vitamins B2 and pellagra preventive factor, whereas vitamins B1, B5, B6, B9, B12 and B15 caused a decline of the vitamin A level in the blood. During treatment of psoriatic patients with pyrogenal the content of vitamin A in the blood increased, while methotrexate therapy caused it to decrease. Vitamin A appears to be effective in the treatment of various forms of psoriasis both alone and in combination with methotrexate and vitamins B1, B5, B6, B9, B12 and B15

Pyridoxine metabolism in patients with skin leishmaniasis in Libya

Epidemiological screening carried out in Libya revealed 1539 patients with zoonotic skin leishmaniasis who were treated, with consideration for the indications, by glucantine, lincocine, vilbramycin, keflex, amoxil, tigason, nisoral, and levamisole. Good results were attained in 1237 (80.3%) patients. In 302 (19.7%) patients the treatment was ineffective; laboratory tests revealed in their blood a marked deficit of pyridoxine. An extra course of therapy of these patients with vitamin B6 preparations pyriditol and pyridoxal phosphate was conducive to complete cure of these patients and recovery of normal pyridoxine level in the blood

Blood serum vitamin a levels in African children with dermatoses; clinical features and treatment

235 African children aged 6 months to 7 years with some dermatoses were investigated. Reduced blood serum vitamin A concentrations were found in all patients with pyoderma (11.7 ± 4.0 mkg%), dermatitis and eczema (10.2 ± 2.8 mkg%) and cutaneous leishmaniasis (9.5 ± 2.6 mkg%). The best results of therapy for these dermatoses were obtained with retinol palmitate in multiple modality treatment. This effects was accompanied with normalization of vitamin A levels in blood serum (24.7 ± 4.1 mkg%) and decline of skin disorders